Clinical Trials Logo

Tricuspid Regurgitation clinical trials

View clinical trials related to Tricuspid Regurgitation.

Filter by:
  • Active, not recruiting  
  • Page 1 ·  Next »

NCT ID: NCT05064514 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Investigation of a Transcatheter Tricuspid Valved Stent Graft in Patients With Carcinoid Heart Disease

TRICAR
Start date: April 6, 2022
Phase: N/A
Study type: Interventional

The purpose of this investigation is to see if the TRICENTO Valved Stent Graft implant reduces tricuspid regurgitation (TR) and improves the symptoms and quality of life in 15 participants with carcinoid heart disease, and who are not able to have a new valve via a surgical procedure.

NCT ID: NCT05006443 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Staging Classification of Severe Tricuspid Regurgitation Using Novel Cardiac Imaging Techniques

Start date: January 14, 2022
Phase: N/A
Study type: Interventional

The purpose of this research is to assess the severity of tricuspid regurgitation (a disorder in which the tricuspid valve in the heart does not close tight enough) using cardiac magnetic resonance imaging (MRI).

NCT ID: NCT04570098 Active, not recruiting - Heart Failure Clinical Trials

Prevalence and Prognostic Relevance of Tricuspid Regurgitation in Different Heart Failure Entities

Start date: July 26, 2020
Phase:
Study type: Observational

The present study includes patients with tricuspid regurgitation and heart failure diagnosed with echocardiography. The aim is to evaluate the physical performance of patients with tricuspid regurgitation and heart failure, to observe the course of the diseases and to allow a better understanding of new therapy options.

NCT ID: NCT04559256 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Tricuspid Cardiopulmonary Exercise Study

TRCPET
Start date: January 1, 2020
Phase: N/A
Study type: Interventional

Tricuspid regurgitation (TR), which in close to 90% of cases is functional as a consequence of left-sided heart failure, left heart valve abnormalities or pulmonary (vascular) disease, is associated with adverse patient outcomes . Due to the increased risk of surgical tricuspid valve repair or replacement compared to surgery in left-sided valve disease TR is often undertreated. Treatment options for the tricuspid valve have so far been limited. Conservative therapy over longer. periods usually results in refractoriness to diuretic treatment. Surgical therapy is associated with a high rate of in-hospital mortality (8.8%), the cause of which is not yet fully understood but may partly be explained by the hemodynamic challenge that cardiopulmonary bypass imposes on the often already-dysfunctional right ventricle. Recently, transcatheter strategies have been developed and have shown promising results. Despite the promising data it has so far not be determined objectively whether interventional treatment of isolated tricuspid regurgitation improves exercise capacity and what role right ventricular function plays in this setting.

NCT ID: NCT04289870 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Innoventric Trillium™ Stent Graft First-in-Human (FIH) Study

Start date: June 24, 2020
Phase: N/A
Study type: Interventional

A prospective, single-arm, multi-center first-in-human (FIH) study to evaluate the safety and performance of the Innoventric Trillium™ Stent Graft System. Twenty (20) patients in 8 investigational sites will be enrolled. All enrolled study patients will be assessed at baseline, during the procedure, at discharge, after 1 month, 3 months, 6 months, 1 year, 1.5 years, 2 years, and 3 years following the index procedure.

NCT ID: NCT03904147 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

TRILUMINATE Pivotal Trial

Start date: August 21, 2019
Phase: N/A
Study type: Interventional

The primary objective of this trial is to demonstrate the safety and effectiveness of the TriClip device in improving clinical outcomes in symptomatic patients with severe tricuspid regurgitation (TR), who are at intermediate or greater estimated risk for mortality or morbidity with tricuspid valve surgery. This randomized controlled trial will compare the investigational device (TriClip device) to Control (Medical Therapy).

NCT ID: NCT03779490 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Transcatheter Repair of Tricuspid Regurgitation With Edwards Cardioband TR System Post Market Study (TriBAND)

TriBAND
Start date: July 24, 2019
Phase:
Study type: Observational

The purpose of the study is to assess the safety and the effectiveness of the Cardioband Tricuspid Reconstruction System.

NCT ID: NCT03745313 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Edwards CLASP TR EFS

CLASP TR EFS
Start date: February 5, 2019
Phase: N/A
Study type: Interventional

Early feasibility study to assess the safety and performance of the Edwards PASCAL Transcatheter Valve Repair System in tricuspid regurgitation

NCT ID: NCT03382457 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Clinical Study of Edwards Cardioband Tricuspid Valve Reconstruction System

Start date: July 1, 2018
Phase: N/A
Study type: Interventional

Clinical Study of the Edwards Cardioband Tricuspid Valve Reconstruction System (formerly "Edwards Cardioband™ Tricuspid Valve Reconstruction System Early Feasibility Study")

NCT ID: NCT02339974 Active, not recruiting - Clinical trials for Tricuspid Regurgitation

Heterotopic Implantation Of the Edwards-Sapien Transcatheter Aortic Valve in the Inferior VEna Cava for the Treatment of Severe Tricuspid Regurgitation (HOVER)

HOVER
Start date: January 2015
Phase: Phase 3
Study type: Interventional

The goal of this study is to determine the short term safety (<30 days) and efficacy (6 months) of the heterotopic implantation of the Edwards-Sapien XT valve in the inferior vena cava for the treatment of severe tricuspid regurgitation in patients who are inoperable or at a very high surgical risk for tricuspid valve replacement.